Mon, November 13, 2023
Sun, November 12, 2023
Fri, November 10, 2023
Thu, November 9, 2023

Richard Newitter Maintained (TMCI) at Strong Buy with Decreased Target to $12 on, Nov 10th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-12-on-nov-10th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Richard Newitter of Truist Securities, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Decreased Target from $17 to $12 on, Nov 10th, 2023.

Richard has made no other calls on TMCI in the last 4 months.



There are 3 other peers that have a rating on TMCI. Out of the 3 peers that are also analyzing TMCI, 1 agrees with Richard's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • George Sellers of "Stephens & Co." Reiterated at Hold and Held Target at $25 on, Tuesday, September 12th, 2023


These are the ratings of the 2 analyists that currently disagree with Richard


  • Danielle Antalffy of "UBS" Initiated at Strong Buy and Held Target at $24 on, Friday, September 29th, 2023
  • Ryan Zimmerman of "BTIG" Maintained at Strong Buy with Decreased Target to $28 on, Monday, August 28th, 2023

Publication Contributing Sources